ivy tirzepatide activates both GLP‑1 and GIP receptors, two hormone pathways that help regulate appetite, blood sugar, and how the body uses energy. This dual action is designed to promote fat loss while Tirzepatide activates both GLP‑1 and

Some signs to look out for: Bloating, indigestion, or heartburn Digestive discomforts, such as gas or cramping Irregular or sluggish bowel movements Low energy or poor nutrient absorption It is also important to note that if these symptoms are persistent, painful and impacting daily life, speak to your GP or a health professional

Anxiety has been reported as an adverse event with tirzepatide, though it occurs infrequently and represents a small fraction of total adverse events reporte...

Explore the evidence, side effect management tips, and UK clinical guidance for this investigational once-weekly injectable therapy.

Medicare began covering weight-loss drugs for millions of Americans Wednesday for the first time.

Novo Nordisk has innovated a subcutaneous formulation of semaglutide, branded as Ozempic, which functions as a modified human glucagon-like peptide-1 (GLP-1) analogue

Discover how combining HRT and GLP-1 therapy helps women in perimenopause and menopause achieve better weight loss, improved metabolic health, and long-term wellness